Back to Results
First PageMeta Content
Brain / Mood stabilizers / Carbonic anhydrase inhibitors / Medical terms / Topiramate / Lacosamide / Lennox–Gastaut syndrome / Lamotrigine / Generalised epilepsy / Anticonvulsants / Epilepsy / Medicine


PUBLIC SUMMARY DOCUMENT Product: Lacosamide, tablets, 50 mg, 100 mg, 150 mg and 200 mg, Vimpat® Sponsor: UCB Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application
Add to Reading List

Document Date: 2014-10-01 21:56:22


Open Document

File Size: 145,77 KB

Share Result on Facebook
UPDATE